NMDA receptors are ligand-gated ion channels permeable to calcium and play a critical role in excitatory synaptic transmission, synaptic plasticity, and excitotoxicity. They are heteromeric complexes of NR1 combined with NR2A-D and/or NR3A-B subunits that are activated by glutamate and glycine and whose activity is modulated by allosteric modulators. In this study, patch-clamp recordings from human embryonic kidney 293 cells expressing NR1/NR2 receptors were used to study the molecular mechanism of the endogenous neurosteroid 20-oxo-5beta-pregnan-3alpha-yl sulfate (3alpha5betaS) action at NMDA receptors. 3alpha5betaS was a twofold more potent inhibitor of responses mediated by NR1/NR2C-D receptors than those mediated by NR1/NR2A-B receptors. The structure of the extracellular loop between the third and fourth transmembrane domains of the NR2 subunit was found to be critical for the neurosteroid inhibitory effect. The degree of 3alpha5betaS-induced inhibition of responses to glutamate was voltage independent, with recovery lasting several seconds. In contrast, application of 3alpha5betaS in the absence of agonist had no effect on the subsequent response to glutamate made in the absence of the neurosteroid. A kinetic model was developed to explain the use-dependent action of 3alpha5betaS at NMDA receptors. In accordance with the model, 3alpha5betaS was a less potent inhibitor of NMDA receptor-mediated EPSCs and responses induced by a short application of 1 mm glutamate than of those induced by a long application of glutamate. These results suggest that 3alpha5betaS is a use-dependent but voltage-independent inhibitor of NMDA receptors, with more potent action at tonically than at phasically activated receptors. This may be important in the treatment of excitotoxicity-induced neurodegeneration.

Institute of Physiology Academy of Sciences of the Czech Republic 142 20 Prague 4 Czech Republic

Zobrazit více v PubMed

Abdrachmanova G, Teisinger J, Vlachova V, Vyklicky L (2000) Molecular and functional properties of synaptically activated NMDA receptors in neonatal motoneurons in rat spinal cord slices. Eur J Neurosci 12: 955–963. PubMed

Abdrachmanova G, Chodounska H, Vyklicky Jr L (2001) Effects of steroids on NMDA receptors and excitatory synaptic transmission in neonatal motoneurons in rat spinal cord slices. Eur J Neurosci 14: 495–502. PubMed

Anson LC, Chen PE, Wyllie DJ, Colquhoun D, Schoepfer R (1998) Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors. J Neurosci 18: 581–589. PubMed PMC

Arnostova LM, Pouzar V, Drasar P (1992) Synthesis of the sulfates derived from 5 alpha-cholestane-3 beta,6 alpha-diol. Steroids 57: 233–235. PubMed

Banke TG, Traynelis SF (2003) Activation of NR1/NR2B NMDA receptors. Nat Neurosci 6: 144–152. PubMed

Benveniste M, Mayer ML (1995) Trapping of glutamate and glycine during open channel block of rat hippocampal neuron NMDA receptors by 9-aminoacridine. J Physiol (Lond) 483: 367–384. PubMed PMC

Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31–39. PubMed

Bowlby MR (1993) Pregnenolone sulfate potentiation of N-methyl-d-aspartate receptor channels in hippocampal neurons. Mol Pharmacol 43: 813–819. PubMed

Chen N, Luo T, Raymond LA (1999) Subtype-dependence of NMDA receptor channel open probability. J Neurosci 19: 6844–6854. PubMed PMC

Colquhoun D, Sakmann B (1985) Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate. J Physiol (Lond) 369: 501–557. PubMed PMC

Danysz W, Parsons CG, Mobius H, Stoffler A, Quack G (2000) Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease—a unified glutamatergic hypothesis on the mechanism of action. Neurotox Res 2: 85–97. PubMed

Dingledine R, Borges K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51: 7–61. PubMed

Doble A (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81: 163–221. PubMed

Flint AC, Maisch US, Weishaupt JH, Kriegstein AR, Monyer H (1997) NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex. J Neurosci 17: 2469–2476. PubMed PMC

Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85–100. PubMed

Hollmann M, Boulter J, Maron C, Beasley L, Sullivan J, Pecht G, Heinemann S (1993) Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron 10: 943–954. PubMed

Horak M, Vlcek K, Petrovic M, Chodounska H, Vyklicky Jr L (2004) Molecular mechanism of pregnenolone sulfate action at NR1/NR2B receptors. J Neurosci 24: 10318–10325. PubMed PMC

Horak M, Vlcek K, Chodounska H, Vyklicky Jr L (2005) Subtype-dependence of NMDA receptor modulation by pregnenolone sulfate. Neuroscience, in press. PubMed

Huettner JE, Bean BP (1988) Block of N-methyl-d-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci USA 85: 1307–1311. PubMed PMC

Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, Nakanishi S (1993) Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits. J Biol Chem 268: 2836–2843. PubMed

Jahr CE (1992) High probability opening of NMDA receptor channels by l-glutamate. Science 255: 470–472. PubMed

Jang MK, Mierke DF, Russek SJ, Farb DH (2004) A steroid modulatory domain on NR2B controls N-methyl-d-aspartate receptor proton sensitivity. Proc Natl Acad Sci USA 101: 8198–8203. PubMed PMC

Kawato S, Yamada M, Kimoto T (2003) Brain neurosteroids are 4th generation neuromessengers in the brain: cell biophysical analysis of steroid signal transduction. Adv Biophys 37: 1–48. PubMed

Kemp JA, McKernan RM (2002) NMDA receptor pathways as drug targets. Nat Neurosci [Suppl] 5: 1039–1042. PubMed

Krupp JJ, Vissel B, Heinemann SF, Westbrook GL (1998) N-terminal domains in the NR2 subunit control desensitization of NMDA receptors. Neuron 20: 317–327. PubMed

Kuryatov A, Laube B, Betz H, Kuhse J (1994) Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins. Neuron 12: 1291–1300. PubMed

Lapchak PA (2004) The neuroactive steroid 3-alpha-ol-5-beta-pregnan-20-one hemisuccinate, a selective NMDA receptor antagonist improves behavioral performance following spinal cord ischemia. Brain Res 997: 152–158. PubMed

Laube B, Hirai H, Sturgess M, Betz H, Kuhse J (1997) Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 18: 493–503. PubMed

Laube B, Kuhse J, Betz H (1998) Evidence for a tetrameric structure of recombinant NMDA receptors. J Neurosci 18: 2954–2961. PubMed PMC

Laurie DJ, Seeburg PH (1994) Ligand affinities at recombinant N-methyl-d-aspartate receptors depend on subunit composition. Eur J Pharmacol 268: 335–345. PubMed

Lester RA, Jahr CE (1992) NMDA channel behavior depends on agonist affinity. J Neurosci 12: 635–643. PubMed PMC

Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, Auberson YP, Wang YT (2004) Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304: 1021–1024. PubMed

MacDonald JF, Miljkovic Z, Pennefather P (1987) Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J Neurophysiol 58: 251–266. PubMed

MacDonald JF, Bartlett MC, Mody I, Pahapill P, Reynolds JN, Salter MW, Schneiderman JH, Pennefather PS (1991) Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J Physiol (Lond) 432: 483–508. PubMed PMC

Malayev A, Gibbs TT, Farb DH (2002) Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br J Pharmacol 135: 901–909. PubMed PMC

Mayer ML, Vyklicky Jr L, Westbrook GL (1989) Modulation of excitatory amino acid receptors by group IIB metal cations in cultured mouse hippocampal neurones. J Physiol (Lond) 415: 329–350. PubMed PMC

Mealing GA, Lanthorn TH, Small DL, Murray RJ, Mattes KC, Comas TM, Morley P (2001) Structural modifications to an N-methyl-d-aspartate receptor antagonist result in large differences in trapping block. J Pharmacol Exp Ther 297: 906–914. PubMed

Mellon SH, Griffin LD (2002) Synthesis, regulation, and function of neurosteroids. Endocr Res 28: 463. PubMed

Mendes P (1993) GEPASI: a software package for modelling the dynamics, steady states and control of biochemical and other systems. Comput Appl Biosci 9: 563–571. PubMed

Mendes P (1997) Biochemistry by numbers: simulation of biochemical pathways with Gepasi 3. Trends Biochem Sci 22: 361–363. PubMed

Mendes P, Kell D (1998) Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation. Bioinformatics 14: 869–883. PubMed

Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217–1221. PubMed

Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529–540. PubMed

Neher E (1983) The charge carried by single-channel currents of rat cultured muscle cells in the presence of local anaesthetics. J Physiol (Lond) 339: 663–678. PubMed PMC

Park-Chung M, Wu FS, Farb DH (1994) 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol Pharmacol 46: 146–150. PubMed

Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6: 2311–2322. PubMed

Popescu G, Auerbach A (2003) Modal gating of NMDA receptors and the shape of their synaptic response. Nat Neurosci 6: 476–483. PubMed

Rao CR (1973) Linear statistical infererence and its applications, Chaps 4, 5. New York: Wiley.

Rogawski MA (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14: 325–331. PubMed

Sattler R, Tymianski M (2001) Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 24: 107–129. PubMed

Sattler R, Xiong Z, Lu WY, MacDonald JF, Tymianski M (2000) Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. J Neurosci 20: 22–33. PubMed PMC

Spivak V, Lin A, Beebe P, Stoll L, Gentile L (2004) Identification of a neurosteroid binding site contained within the GluR2–S1S2 domain. Lipids 39: 811–819. PubMed

Stuart GJ, Dodt HU, Sakmann B (1993) Patch-clamp recordings from the soma and dendrites of neurons in brain slices using infrared video microscopy. Pflügers Arch 423: 511–518. PubMed

Tong G, Jahr CE (1994) Regulation of glycine-insensitive desensitization of the NMDA receptor in outside-out patches. J Neurophysiol 72: 754–761. PubMed

Vissel B, Krupp JJ, Heinemann SF, Westbrook GL (2002) Intracellular domains of NR2 alter calcium-dependent inactivation of N-methyl-d-aspartate receptors. Mol Pharmacol 61: 595–605. PubMed

Vyklicky Jr L, Benveniste M, Mayer ML (1990) Modulation of N-methyl-d-aspartic acid receptor desensitization by glycine in mouse cultured hippocampal neurones. J Physiol (Lond) 428: 313–331. PubMed PMC

Weaver Jr CE, Wu FS, Gibbs TT, Farb DH (1998) Pregnenolone sulfate exacerbates NMDA-induced death of hippocampal neurons. Brain Res 803: 129–136. PubMed

Williams K (1993) Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44: 851–859. PubMed

Woodhull AM (1973) Ionic blockage of sodium channels in nerve. J Gen Physiol 61: 687–708. PubMed PMC

Wu FS, Gibbs TT, Farb DH (1991) Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor. Mol Pharmacol 40: 333–336. PubMed

Zorumski CF, Mennerick S, Isenberg KE, Covey DF (2000) Potential clinical uses of neuroactive steroids. Curr Opin Investig Drugs 1: 360–369. PubMed

Altered Steroidome in Women with Multiple Sclerosis

The Neuroactive Steroid Pregnanolone Glutamate: Anticonvulsant Effect, Metabolites and Its Effect on Neurosteroid Levels in Developing Rat Brains

Endogenous neurosteroids pregnanolone and pregnanolone sulfate potentiate presynaptic glutamate release through distinct mechanisms

Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity

Site of Action of Brain Neurosteroid Pregnenolone Sulfate at the N-Methyl-D-Aspartate Receptor

Activation of Adrenal Steroidogenesis and an Improvement of Mood Balance in Postmenopausal Females after Spa Treatment Based on Physical Activity

Strong Inhibitory Effect, Low Cytotoxicity and High Plasma Stability of Steroidal Inhibitors of N-Methyl-D-Aspartate Receptors With C-3 Amide Structural Motif

Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives

Block of NMDA receptor channels by endogenous neurosteroids: implications for the agonist induced conformational states of the channel vestibule

Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models

Access of inhibitory neurosteroids to the NMDA receptor